792 related articles for article (PubMed ID: 8376931)
21. Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution.
Echchakir H; Dorothée G; Vergnon I; Menez J; Chouaib S; Mami-Chouaib F
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9358-63. PubMed ID: 12093915
[TBL] [Abstract][Full Text] [Related]
22. The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100.
Zarour H; De Smet C; Lehmann F; Marchand M; Lethé B; Romero P; Boon T; Renauld JC
J Invest Dermatol; 1996 Jul; 107(1):63-7. PubMed ID: 8752841
[TBL] [Abstract][Full Text] [Related]
23. TCR V beta 3+ and V beta 6+ CTL recognize tumor-associated antigens related to HER2/neu expression in HLA-A2+ ovarian cancers.
Peoples GE; Yoshino I; Douville CC; Andrews JV; Goedegebuure PS; Eberlein TJ
J Immunol; 1994 May; 152(10):4993-9. PubMed ID: 7909829
[TBL] [Abstract][Full Text] [Related]
24. Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines.
Kirkin AF; Petersen TR; Olsen AC; Li L; thor Straten P; Zeuthen J
Cancer Immunol Immunother; 1995 Aug; 41(2):71-81. PubMed ID: 7656272
[TBL] [Abstract][Full Text] [Related]
25. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes.
Storkus WJ; Zeh HJ; Maeurer MJ; Salter RD; Lotze MT
J Immunol; 1993 Oct; 151(7):3719-27. PubMed ID: 7690811
[TBL] [Abstract][Full Text] [Related]
26. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
Solheim JC; Alexander-Miller MA; Martinko JM; Connolly JM
J Immunol; 1993 Feb; 150(3):800-11. PubMed ID: 8380825
[TBL] [Abstract][Full Text] [Related]
27. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
Gervois N; Heuze F; Diez E; Jotereau F
Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
[TBL] [Abstract][Full Text] [Related]
28. Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4- CTL lines.
Fisk B; Flytzanis CN; Pollack MS; Wharton JT; Ioannides CG
Scand J Immunol; 1994 Dec; 40(6):591-600. PubMed ID: 7848491
[TBL] [Abstract][Full Text] [Related]
29. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
Stevens EJ; Jacknin L; Robbins PF; Kawakami Y; el Gamil M; Rosenberg SA; Yannelli JR
J Immunol; 1995 Jan; 154(2):762-71. PubMed ID: 7814882
[TBL] [Abstract][Full Text] [Related]
30. T-cell receptor gene structures of HLA-A26-restricted cytotoxic T lymphocyte lines against human autologous pancreatic adenocarcinoma.
Ueda D; Sato N; Matsuura A; Sasaki A; Takahashi S; Ikeda H; Wada Y; Kikuchi K
Jpn J Cancer Res; 1995 Jul; 86(7):691-7. PubMed ID: 7559088
[TBL] [Abstract][Full Text] [Related]
31. Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.
Schøller J; thor Straten P; Birck A; Siim E; Dahlström K; Drzewiecki KT; Zeuthen J
Cancer Immunol Immunother; 1994 Oct; 39(4):239-48. PubMed ID: 7954526
[TBL] [Abstract][Full Text] [Related]
32. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
[TBL] [Abstract][Full Text] [Related]
33. Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes.
Bernhard H; Jäger E; Maeurer MJ; Meyer zum Büschenfelde KH; Knuth A
Tissue Antigens; 1996 Jul; 48(1):22-31. PubMed ID: 8864171
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic activity and lymphokine production of T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ cytotoxic T lymphocyte (CTL) clones recognizing HLA-A2 and HLA-A2 mutants. Recognition of TCR-gamma delta+ CTL clones is affected by mutations at positions 152 and 156.
Spits H; Paliard X; Engelhard VH; de Vries JE
J Immunol; 1990 Jun; 144(11):4156-62. PubMed ID: 2111341
[TBL] [Abstract][Full Text] [Related]
35. The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys.
Chen ZW; Shen L; Regan JD; Kou Z; Ghim SH; Letvin NL
J Immunol; 1996 Feb; 156(4):1469-75. PubMed ID: 8568249
[TBL] [Abstract][Full Text] [Related]
36. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.
Rivoltini L; Barracchini KC; Viggiano V; Kawakami Y; Smith A; Mixon A; Restifo NP; Topalian SL; Simonis TB; Rosenberg SA
Cancer Res; 1995 Jul; 55(14):3149-57. PubMed ID: 7541714
[TBL] [Abstract][Full Text] [Related]
37. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.
Lehner PJ; Wang EC; Moss PA; Williams S; Platt K; Friedman SM; Bell JI; Borysiewicz LK
J Exp Med; 1995 Jan; 181(1):79-91. PubMed ID: 7807026
[TBL] [Abstract][Full Text] [Related]
38. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
[TBL] [Abstract][Full Text] [Related]
39. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
Kawakami Y; Eliyahu S; Sakaguchi K; Robbins PF; Rivoltini L; Yannelli JR; Appella E; Rosenberg SA
J Exp Med; 1994 Jul; 180(1):347-52. PubMed ID: 7516411
[TBL] [Abstract][Full Text] [Related]
40. Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes.
Mazzocchi A; Storkus WJ; Traversari C; Tarsini P; Maeurer MJ; Rivoltini L; Vegetti C; Belli F; Anichini A; Parmiani G; Castelli C
J Immunol; 1996 Oct; 157(7):3030-8. PubMed ID: 8816412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
